CoChat
Sign Up
Cited by 159Abdominal vascular conditions and treatmentsVascular anomalies and interventionsRenal and Vascular Pathologies

Percutaneous transluminal angioplasty and stenting in the treatment of chronic mesenteric ischemia: results and longterm followup11Dr Matsumoto owns stock in Johnson and Johnson, and Boston Scientific.

Matsumoto, Alan H, Angle, J.Fritz, Spinosa, David J, Hagspiel, Klaus D, Cage, Dorothy L, Leung, Daniel A, Kern, John A, Tribble, Curtis G +1 more·2002·Journal of the American College of Surgeons
DOI 10.1016/s1072-7515(01)01062-6
Open this paper in CoChat — free account

Abstract

BACKGROUND: The purpose of this study was to review the results of percutaneous transluminal angioplasty (PTA), stenting, or both in the treatment of patients who present with symptoms and angiographic findings most consistent with chronic mesenteric ischemia. STUDY DESIGN: A retrospective analysis of 33 consecutive patients from a single institution who underwent PTA, stenting, or both for treatment of symptoms most characteristic of chronic mesenteric ischemia was performed. RESULTS: There were 12 men and 21 women with a mean age of 63 years (range 40 to 89 years). Median weight loss was 28 lb (range 6 to 80 lb). Postprandial pain was present in 88% of the patients (29 of 33). All lesions treated were stenoses. PTA alone was performed in 21 patients (32 vessels), and PTA and stenting were performed in 12 patients (15 vessels). PTA was technically successful in 26 of 32 vessels (81.3%); PTA plus stenting was technically successful in 15 of 15 vessels (100%) (p = 0.073). Complete alleviation of symptoms occurred immediately in 27 of the patients (82%), and 2 patients (6%) had significant improvement in symptoms. There were four immediate clinical failures (12%): two patients were found to have occult malignancy and one had immediate relief of symptoms after surgical release of the median arcuate ligament. Followup data were obtained in all patients with clinically successful procedures (mean 38 months, median 25 months, range 1 to 123 months). Angiographic followup was available in 52% of the patients (15 of 29), at a mean of 20 months. The primary longterm clinical success rate was 83.3% (24 of 29). Four of the five patients with recurrent symptoms were successfully retreated with endovascular therapy. The primary assisted longterm clinical success rate was 96.6% (28 of 29). The 5-year survival rate was 76.1%. Major complications occurred in 13% of the procedures, with a 30-day mortality rate of 0%. CONCLUSION: Endovascular therapy for treatment of mesenteric arterial stenoses is effective in the treatment of patients with symptoms and angiographic findings characteristic of chronic mesenteric ischemia.

Integrity signals

Registry

Crossref · 10.1016/s1072-7515(01)01062-6

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a small study, PTBA plus stenting had better technical success and patency rate when compared with PTBA alone.

    “Matsumoto et al[117] found in a small study that PTBA plus stenting had better technical success and patency rate when compared with PTBA alone[117].”

    From Ischemic bowel disease in 2021. (2021) · cites this paper as [117]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Matsumoto, A. H., Angle, J. F., Spinosa, D. J., Hagspiel, K. D., Cage, D. L., Leung, D. A., Kern, J. A., Tribble, C. G., & Kron, I. L.
Affiliations
University of Virginia Health System (US)
ORCID
Venue
Journal of the American College of Surgeons
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2002-01
Volume
194
Issue
1
Pages
S22-S31
ISSN
1072-7515 (ISSN-L)
DOI
10.1016/s1072-7515(01)01062-6
OpenAlex
W1579809332
Cited by
159
References
25
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 3 · 2015: 4 · 2014: 9 · 2013: 9 · 2012: 14
FWCI
7.30
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American College of Surgeons (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Surgery › Vascular anomalies and interventions
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal and Vascular Pathologies
Keywords
percutaneous transluminal angioplasty, endovascular treatment, mesenteric artery stenosis, postprandial pain, long-term clinical outcomes, recurrent symptoms, survival, complications, occult malignancy, median arcuate ligament release, weight loss, angiographic follow-up
MeSH terms
Adult, Aged, Angioplasty, Balloon, Cause of Death, Female, Humans, Ischemia, Male, Mesentery, Middle Aged, Postoperative Period, Retrospective Studies, Stents, Abdominal Pain, Chi-Square Distribution, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review